baber/WOPTO huggingface dataset:
Patent FI-951934-A0 (FI)
Inventor: KIVIMAA JUHA
IPC: D21F3/02
Filed: 1995-04-24
Abstract: The invention concerns a press section of a paper machine, which press section comprises at least two press nips (NP1,NP2,NP10,N2,N3) placed one after the other. Of these nips, at least the first nip is an extended nip (NP1) or an at least to some extent extended roll nip (NP10). The last nip (N2;NP2;N3) in the press section is placed on a level higher (H) than the preceding nip (NP1;NP2;NP10). The first nip (NP1;NP10) and/or, when more than two nips are employed, the nip (NP2) that precedes the last nip (N3) is/are provided with two press fabrics (16,17;27,28) that receive water. The paper web (W) is transferred on the lower fabric of said press fabrics onto the upper fabric (38;38A) of the last nip (N2;NP2;N3). On the lower face of said fabric, the web (W) is transferred into the last nip (N2; NP2;N3). After the web (W) transfer point, the upper fabric (38;38A) of the last nip (N2;NP2;N3) has a relatively short (L0) upwards inclined run. After this, the upper fabric (38;38B) is turned, being guided by the lower roll (40;31) of the last nip (N2;NP2;N3), over a considerable sector (a1). The last nip (N2;NP2;N3) is placed after, or at the vicinity of, the topmost point of the lower roll (40;31) that forms said nip. The point of transfer (TR) of the web (W) onto the drying wire (45) of the first group (R1) in the dryer section following after the press section is placed underneath the level of the last nip (N2;NP2;N3). <IMAGE>
Patent FI-962958-A0 (FI)
Inventor: BENDIG MARY M
IPC: A61P7/00
Filed: 1996-07-24
Abstract: The invention provides humanized immunoglobulins that specifically bind to the VLA-4 ligand, and methods of treatment using the same. The methods are particularly useful for the treatment of multiple sclerosis.
Patent FI-963692-A0 (FI)
Inventor: BROOKS PETER
IPC: C12P21/08
Filed: 1996-09-18
Abstract: Angiogenesis is inhibited in a tissue by admin. of a compsn. comprising an alpha vbeta 3 antagonist.
Patent FI-971406-A0 (FI)
Inventor: DAVIS SAMUEL
IPC: A61K47/48
Filed: 1997-04-04
Abstract: The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptor body which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth or differentiation of a cell expressing the TIE-2 receptor, a method of blocking the growth or differentiation of a cell expressing the TIE-2 receptor and a method of attenuating or preventing tumor growth in a human.
Patent IL-62816-A0 (IL)
Title: Process for the manufacture of hydroquinone-monophenyl ethhers
IPC: C07C67/00
Filed: 1981-05-06
Abstract: Hydroquinone-monophenyl ethers and their alkali metal salts of the formula    <IMAGE>  I  (R=H or alkali) are obtained by reacting compounds of the formula    <IMAGE> II  with an excess of a compound of the formula    <IMAGE> III  (Kat=Na, K) in N-methylpyrrolidone at 230 DEG -260 DEG  C.
Patent IL-65190-A0 (IL)
Title: Biologically active heterocyclic compounds
IPC: C07D333/38
Filed: 1982-03-08
Abstract: N-Heterocyclylmethyl amides of formula (I):wherein R<sup>1</sup> is optionally substituted alkyl, alkenyl, aryl, or heterocyclyl; R<sup>2</sup> is hydrogen, C<sub>1-4</sub> alkyl, or C<sub>3-4</sub> alkenyl E is CN, CSNH<sub>2</sub>, alkoxycarbonyl, or-CONR<sup>4</sup>R<sup>5</sup> wherein R<sup>4</sup> and R<sup>5</sup> are H or optionally substituted alkyl or alkenyl; X is oxygen or sulphur; and R<sup>3</sup> is H, or one or more Me or Cl. The compounds are useful as herbicides and fungicides.
Patent IL-79443-A0 (IL)
Title: Plant for the electrolytic production of reactive metals in molten salt baths
IPC: C25C3/26
Filed: 1986-07-17
Abstract: The plant for the electrolytic production of a metal in a molten salt bath by deposition at the cathode in the solid state includes an outer casing (2), means (16a, 20a) for maintaining an atmosphere inert to the metal to be produced in the casing, a container (6) within the casing and arranged to contain the molten salt bath and having a movable cover (48), a plurality of electrodes (52) suspended in the molten salt bath each bearing on means (54a, 54b) for supporting it and connecting it electrically, the means comprising for each of the electrodes a pair of electrically conductive elements (56) facing each other and supported respectively by two opposite walls of the container and handling means (8) associated with the outer casing for removing any one of the electrodes from the container after raising of the movable cover.
Patent IL-88034-A0 (IL)
Title: Mutant acidic fibroblast growth factor,its preparation and pharmaceutical compositions containing it
IPC: A61P7/02
Filed: 1988-10-13
Abstract: Novel genes coding for mutant bovine and human aFGF are constructed. The unique genes are derived from genes encoding recombinant bovine and human aFGF by specific point mutations. Each gene construct is inserted into an expression vector which is used to transform an appropriate host. The transformed host cells produce unique mutant recobinant aFGF, human or bovine, which is purified and has enhanced or improved biological activity in the absence of heparin compared to the unmutated forms.
Patent IL-96191-A0 (IL)
Title: Method and apparatus for controlling a fluid compression system
IPC: F04B49/06
Filed: 1990-10-31
Abstract: An apparatus includes a compressor for compressing fluid including a sensor capable of sensing at least one function relative to the operation of the compressor. A controller controls the compressor causing the value of said one function to be within a predetermined parameter. A computer overrides the independent response of the controller wherein the controller acts in response to the computer, the computer being separate from said controller. The computer may act as a sequencing computer or as a test computer.
Patent AU-PR847301-A0 (AU)
Title: Endoluminal prostheses for curved lumens
IPC: A61F2/89
Filed: 2001-10-26
Abstract: A prosthetic device ( 1 ) adapted for the carriage of fluids therethrough within a human or animal body and to be placed in or replace a curved lumen. The prosthetic device has a control arrangement to control the length of one side with respect to the other side so that the device can be curved insitu to fit the curved lumen. The control arrangement can be an expansion restriction arrangement or a length reduction arrangement. The prosthesis can be stented or unstented and be formed from a tubular or corrugated material.
Patent FI-20001817-A0 (FI)
Inventor: KIVELAE JOUNI
IPC: G01F23/284
Filed: 2000-08-16
Abstract: The invention relates to a catalyst feeding system fortank containing solid catalyst mixed with a carrier fluid. The tank system comprises a cylinder tank and a float (1) slidable in the cylindertank, and the catalyst mixture is fed into and dosed out of the cylinder tank on one side of the float. The cylinder tank is provided with a radar level gauge (8) for determining the position of the float (1) in the cylindertank. By means of the radar level gauge, the position of the float and thus the dosing of the catalyst can be measured reliably.
Patent IL-101082-A0 (IL)
Title: Process for recycling amine isomer
IPC: C07C211/38
Filed: 1992-02-27
Abstract: A novel process for converting trans-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine to cis-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine is disclosed. The process involves contacting trans-isomeric N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine, or a mixture of same with up to about an equal part by weight of the corresponding cis-isomer, with a basic equilibration agent like potassium tert.-butoxide in a reaction-inert polar organic solvent to ultimately afford a cis/trans-mixture wherein the amount of cis-amine present in said mixture achieves a constant value of about 2:1 on a weight-by-weight basis. The aforesaid resultant mixture is useful as an intermediate product that ultimately leads to pure cis-(1S) (4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenea mine (sertraline), which is a known antidepressant agent.
Patent IL-108204-A0 (IL)
Title: Preparation of 2-alkyl-6-methyl-n-(1'-methoxy-2'-propyl) - anilines and their chloracetanilides
IPC: C07C217/08
Filed: 1993-12-28
Abstract: A process for the preparation of 2-alkyl-6-methyl-N-(1'methoxy-2'-propyl)-aniline by catalytic reductive alkylation wherein at least one mole equivalent of methoxyacetone is reacted with one mole equivalent of 2-alkyl-6-methyl-aniline in a liquid medium without an additional solvent, in the presence of a platinised carbon catalyst and hydrogen and in the presence of an acid cocatalyst under a hydrogen pressure of between 2 x 10<5> and 1 x 10<6> Pa at a temperature between 20 and 80  DEG C, characterised in that the reaction mixture contains water from the beginning of the reaction and after the hydrogenation, base is added, the reaction mixture is filtered to separate the catalyst and the title compound recovered from the filtrate. The process is particularly useful for the preparation of N-substituted chloracetanilide herbicides.
Patent IL-114008-A0 (IL)
Title: Printed label structure for packaging arrangements
IPC: G09F3/02
Filed: 1995-06-06
Abstract: A cover-forming laminated structure interconnecting a plurality of containers, such as the base members of blister packages (12) each of which is adapted to contain a hydrophilic contact lens in a sterile aqueous solution. More specifically, disclosed is an array of such containers which are interconnected by a single laminated multi-layered material constituting a covering label (24) for the containers, wherein the material may be severed intermediate each of the containers along weakening lines (26) formed by micro-perforations provided therein so as to provide a separate packaging arrangement. The material is imprinted over the surface extent thereof covering the plurality of containers with a specific pattern of indicia and legends configured with the intent of thwarting diverters upon separation of any of the packaging arrangements from the array, through visual evidence afforded by an inspection of the printing pattern. <MATH>
Patent IL-114852-A0 (IL)
Title: A pharmaceutically stable preparation of oxaliplatinum
IPC: A61K31/555
Filed: 1995-08-07
Abstract: PCT No. PCT/IB95/00614 Sec. 371 Date Jan. 24, 1997 Sec. 102(e) Date Jan. 24, 1997 PCT Filed Aug. 7, 1995 PCT Pub. No. WO96/04904 PCT Pub. Date Feb. 22, 1996A pharmaceutically stable oxaliplatinum preparation for parenteral administration comprises an aqueous solution of oxaliplatinum, in a concentration of 1 to 5 mg/ml, and with a pH in the range of 4.5 to 6. The aqueous oxaliplatinum solution is advantageously provided as a ready-to-use preparation in a sealed container.
Patent IL-135271-A0 (IL)
Title: Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
IPC: A61K45/00
Filed: 1998-12-04
Abstract: This invention relates to a method for enhancing the absorption of oil soluble (lipophilic) compounds such as oil soluble vitamins, hormones, nutrients and drugs in an animal. The inventive method comprises administering a lipophilic compound in conjunction with a structured glyceride component characterized in that at least 40% of the glyceride species have: (i) about 33 to 70 wt. % of acyl moieties having 4 to 12 carbon atoms; (ii) about 30 to 67 wt. % of acyl moieties having more than 12 carbon atoms; and (iii) an equivalent carbon number greater than 30 and less than 48. This invention also relates to compositions suitable for administrating to an animal comprising a lipophilic compound and a structured glyceride component characterized in that at least 40% of the glyceride species have: (i) about 33 to 70 wt. % of acyl moieties having 4 to 12 carbon atoms; (ii) about 30 to 67 wt. % of acyl moieties having more than 12 carbon atoms; and (iii) an equivalent carbon number greater than 30 and less than 48. The method and compositions of the invention are especially suited for animals that suffer from lipid malabsorption conditions such as Crohn's disease, Cystic fibrosis, and short bowel syndrome.
Patent IL-140684-A0 (IL)
Title: Medicine nitrate salts
IPC: A61K31/416
Filed: 1999-07-20
Abstract: The present invention relates to nitrate salts of compounds having therapeutic activity in bony disorders, such compounds being characterized in that they contain at least a reactive group capable of being salified with nitric acid.
Patent IL-142002-A0 (IL)
Title: Insulin preparation for pulmonary delivery containing menthol
IPC: A61K47/18
Filed: 1999-10-15
Abstract: A stable, aqueous insulin formulation suitable for pulmonary delivery is disclosed. The formulation comprises human insulin or an analogue thereof, 2 to 5 Zn<2+> ions per six molecules of insulin, 3 to 18 phenolic molecules per six molecules of insulin, and menthol. The characteristic smell of menthol masks the presence of phenols in the formulation without affecting the chemical and physical stability of the formulation.
Patent IL-154314-A0 (IL)
Title: Chromium-containing cemented tungsten carbide body
IPC: C23C30/00
Filed: 2001-07-03
Abstract: A chromium-containing coated cemented tungsten carbide cutting insert that has a substrate and a coating. The substrate comprises between about 10.4 and about 12.7 weight percent cobalt, between about 0.2 and about 1.2 weight percent chromium.
Patent IL-171974-A0 (IL)
Title: Tetrahydrocarbazole derivatives and their pharmaceutical use
IPC: C07D417/12
Filed: 2005-11-15
Abstract: The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
Patent IL-174351-A0 (IL)
Title: Spinel boules, wafers, and methods for fabricating same
IPC: C30B33/00
Filed: 2006-03-16
Abstract: A single crystal spinel wafer is disclosed, including a front face and a back face; and an outer periphery having first and second flats. In certain embodiments, the single crystal wafer has a specific crystallographic orientation, and the flats are provided to extend along desired plane sets. The flats may advantageously identify orientation of cleavage planes, and direction of cleavage of cleavage planes.
Patent IL-177373-A0 (IL)
Title: Process for the production of granules or pellets containing filamentous fungi
IPC: A01N63/30
Filed: 2006-08-08
Abstract: A process for the production of granules or pellets containing filamentous fungi is described comprising the steps of selecting and growing filamentous fungi in a suitable culture medium for a predetermined amount of time, adding a gelling agent and at least one carrier to said culture medium, so as to obtain a mixture, subjecting said mixture to gelling through contact, drop by drop, with a solution containing a calcium salt thus obtaining gelled pellets or granules containing said filamentous fungi and drying said gelled pellets or granules to a moisture content of 13-18%.
Patent IL-177986-A0 (IL)
Title: Inbound roamer multimedia messaging systems
IPC: H04L29/08
Filed: 2006-09-10
Abstract: Inbound Roamer Multimedia Messaging Systems ("IRMMS") are described that transfer Welcome Multimedia Messages ("MM") ("WMM") or Welcome Roaming Content ("WRC") to devices of inbound roamers. The IRMMS transfers MMs to inbound roamers without involving components of the corresponding home network (HPMN). The MMs include text messages, music clips, voice clips, video clips, photographs, and drawings, but are not so limited. Use of the IRMMS eliminates payment by a VPMN with which a subscriber is roaming to the subscriber's HPMN because components of the HPMN are not included in the transfer of the MMs. Thus, charges typically incurred by the VPMN for transmission of free WMM/WRC sent to the inbound roamer via the HPMN are avoided.
Patent IL-184231-A0 (IL)
Title: Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
Filed: 2007-06-26
Abstract: The present invention is related to benzothiophen-2-carbonylguanidine derivatives, a preparation method thereof, and pharmaceutical compositions containing the same. The derivatives have potent inhibitory effect on the sodium/hydrogen exchanger NHE-I, improve the functional recovery of ischemia/reperfusion-induced heart injury in isolated ischemic heart models, and significantly reduce the myocardiac infarct size in in vivo ischemic animal models, thereby showing excellent cardioprotective effects. Also, the derivatives are protective of both neuronal cells and the brain as proven by their protective effects on neuronal cells from necrosis and apoptosis and by their ability to significantly reduce cerebral infarct sizes in in vivo ischemic brain models. The derivatives can be effectively used for the prevention and treatment of ischemic heart diseases such as myocardiac infarction, arrhythmia, angina pectoris and the like, and cerebrovascular diseases such as cerebral stroke and be used as cardioprotective agents to the patients undergoing reperfusion therapy including chemicals such as thrombolytic agents, or surgery such as coronary artery bypass and percutaneous transluminal coronary angioplasty.
Patent IL-192679-A0 (IL)
Title: Aglyco products and uses thereof
IPC: G01N33/53
Filed: 2008-07-08
Abstract: Glycoconjugates, therapeutic compositions containing the glycoconjujates and therapeutic methods of using the glycoconjugates are disclosed. In particular, peptide constituents of aglyco 10B, which are immunogenic epitopes responsible for recognition of antigens by the immune system are provided. These glycoconjugates are useful in prevention of influenza virus binding to cells, treatment of schizophrenia and diagnosing chronic viral disease associated with development of cancer.
Patent RO-125357-A0 (RO)
Title: Orthopedical screw rod and process for increasing bio-compatibility
Inventor: ANTONIAC VASILE IULIAN
IPC: A61B17/64
Filed: 2009-11-27
Abstract: The invention relates to an orthopedical screw rod for being fixed into fractured bones, meant to be used for human or animal surgery intervention. According to the invention, the rod has a length ranging between 150...220 mm and it consists of a cone-shaped point (1), which has, in the median area, a threaded segment which is continued with a threaded section (2), both being adapted in order to be implanted into the bone cortical area, the threading being performed by means of the cone-shaped end (3) and a handle (4) between which there is a recess (5) needed for facilitating the shortening of the orthopedical screw rod, the handle (4) being provided with some grooves (6) which give the rod a self-threading character, the diameters of the threaded section (2) and the handle (4) being in the ratios ranging between 2/3...5/6, the length of the threaded section (2) being approximately 30...40% of the total length of the orthopedical rod, and the point (1) having cut some longitudinal channels (7) with the role of protecting the bone marrow white while inserting the rod, the length ranging between 10...20% of the length of the threaded section (2).
Patent RO-126595-A0 (RO)
Title: Installation for heating water in the sun by using recycled materials
Inventor: MUSTĂŢEA CONSTANTIN
IPC: F24J2/04
Filed: 2011-02-16
Abstract: The invention relates to an installation using the sun rays to prepare domestic warm water. According to the invention, the installation comprises some cylinders (1) made of PET, painted in black, mounted on horizontal rows, by means of some connecting plugs (2), each cylinder (1) being introduced into another transparent cylinder made of PET, having a diameter larger than the diameter of the first cylinder (1), so as to ensure a good thermal insulation, more such rows being mounted in parallel, by means of some connecting hoses (3), the cold water supply being made at the lower side, through a supply valve (R), the warm water being obtained at the upper side, through a discharge hose (5) provided with a vertical plane loop and with a venting valve (4).
Patent RO-130255-A0 (RO)
Title: System for automatic lighting of cross street markings for pedestrian crossing "lumo"
Inventor: TRIFAN ADRIAN-IONUŢ
IPC: E01F9/06
Filed: 2014-11-20
Abstract: The invention relates to a system for automatic lighting of street markings for pedestrian crossings and to a process for making the said street markings. According to the invention, the system comprises several lighting fixtures buried into the pavement, each said fixture consisting of a box () welded to a reinforcing mesh () fixed onto the bottom of a hole dug for the lighting fixtures, the box () having an external frame () and being closed by a detachable cover () provided with an aperture in which another frame () is fixed to protect a secure glass piece (), where the cover () represents the cross street marking, its surface being covered with bitumen which is subsequently painted with light-reflective paint, so that the glass () is located at the level of the practicable road (), while inside the box () there is a LED lighting assembly () supplied from the main or from a photovoltaic installation () mounted on a post () in the vicinity of the pedestrian crossing. The process for making the pedestrian crossing markings comprises the following steps: stripping the pavement of the practicable road along the length and the width of the pedestrian crossing location, fixing a reinforcing mesh () onto the bottom of the resulting hole, mounting a LED lighting assembly () and connecting it to a control panel () mounted on a post () in the vicinity of the pedestrian crossing, detachably mounting the covers () of the lighting fixtures, pouring asphaltic bitumen on the surface of the covers (), between the external frames and the protective frames followed by the subsequent painting with light-reflective paint, mounting a dusk sensor () which will open the electric circuits of the lighting assembly () when a minimum natural light intensity is reached, as well as some laser sensors () and some pressure sensors () having the role of automatically switching-on the lighting assembly () upon the approach of pedestrians.
Patent LU-88106-A1 (LU)
IPC: A61K31/44
Filed: 1992-04-22
Abstract: The invention relates to the use of aromatase inhibitors for contraception in female primates and to a method for contraception in female primates using such substances and to the use of those substances for the preparation of pharmaceutical compositions for contraception in female primates.
Patent MA-21096-A1 (MA)
Inventor: ANN MARIE LAURITZEN
IPC: B01J23/32
Filed: 1987-10-28
Abstract: A composition containing silver, a support, rhenium and at least one further metal, characterized in that the selected amounts of the metals or compounds are such that under conditions of catalytic manufacture of e thylene oxide from ethylene and oxygen the composition comprises a catalytically effective amount of silver, a promoting amount of rhenium or compound thereof and a promoting amount of at least one further metal or compound thereof.